February

Life science entrepreneurs give insight into what they are made of by answering one question. Read more about what keeps life science CEOs up at night.

Young biotech companies sometimes face a valley of death in funding, but a venture capital researcher is challenging that idea. Read more about the early stage funding valley of death.

Convertible debt is a fundraising mechanism used in any stage of a new healthcare business, but it may be especially appealing in the early stages.

Getting a CE Mark in Europe has allowed American medical device makers to commercialize quickly before getting U.S. Food and Drug Administration approval to sell medical devices domestically. Read about how the less stringent European regulation methods are now being questioned.

How do you impress an investor? Here are 10 tips about what to say and how to say it when making your pitch. Read more for ideas you can use in honing your pitch today.

Pfizer Inc. is testing a pilot of a virtual clinical trial program that could be of interest to medical device startups and young pharmaceutical and biotech companies.

StartUp Health classes will begin next month, giving entrepreneurs a structured program to launch a healthcare business. Read more about the program for startup businesses.

Early stage company entrepreneurs have been warned about a "valley of death" for funding. Read about whether it's real or just a myth.

Designing successful mobile health apps is becoming more challenging with the growth of the digital health market. Read about mobile health marketing.

FDA medical device user fees will more than double during the next five years. Read more about why the FDA is increasing its fees.